What is it about?

In patients with augmented renal clearance (ARC), individualized dosing regimens are required to achieve the target trough concentration. In this study, we try to evaluate the validity of dose-adjustment regimen of vancomycin (VCM) in ARC patients.

Featured Image

Why is it important?

We believe that our study makes a significant contribution to the literature because the superiority of this validated nomogram over existing regimens in avoiding toxic concentrations was demonstrated, although the nomogram was challenged by a lack of accuracy in achieving target trough concentrations. However, the nomogram accuracy could be improved by classifying patients based on age, and the present findings indicate the benefits of the nomogram in facilitating the avoidance of subtherapeutic concentrations of VCM in patients who are at risk for augmented renal clearance.

Perspectives

Our findings may contribute to the development of appropriate adjustment of the VCM initial dosage.

Keita Hirai
University of Shizuoka

Read the Original

This page is a summary of: Validation of A Nomogram for Achieving Target Trough Concentration of Vancomycin, Therapeutic Drug Monitoring, August 2018, Wolters Kluwer Health,
DOI: 10.1097/ftd.0000000000000562.
You can read the full text:

Read

Resources

Contributors

The following have contributed to this page